Why CVS Is ‘Insanely Cheap,’ ON Semi a Laggard Catching Up, and Grail Too Expensive to Chase
Jim Cramer commented on three stocks: CVS Health (CVS) is 'insanely cheap' at $86.68, with strong fundamentals and raised guidance. ON Semiconductor (ON) is catching up post-Synaptics deal, trading at $84.00. Grail (GRAL), at $5.7B market cap, is too expensive at 34x sales, according to Cramer.
How this was made
The 30-second read
Why it matters
The piece offers qualitative opinions rather than new primary disclosures; its trading impact depends on how closely traders follow Cramer’s calls.
Market read
Opinion piece with modest relevance; may influence short‑term sentiment for the three named stocks.
What to watch
Potential macro‑economic headwinds could dampen the upside for CVS and ON despite strong fundamentals.
Background
Jim Cramer’s commentary on three stocks, mixing earnings data, guidance, and valuation opinions.
Ticker impact
Cramer highlights CVS's Q2 adjusted EPS beat and raised full-year guidance, calling the stock "insanely cheap" at $86.
likely upward pressure as traders view the stock as undervalued
Cramer’s endorsement and fresh guidance could attract buying interest.
Cramer notes ON Semiconductor’s data‑center revenue surge and the removal of the Synaptics overhang, calling it a catch‑up play.
likely upward pressure as investors see growth in AI data‑center business
Clear growth narrative and recent price rally support a continued upside.
Cramer describes Grail as expensive, trading at 34× sales with speculative FDA risk, despite recent revenue growth.
likely downward pressure due to perceived overvaluation and pending FDA decision
Cramer’s criticism and high sales multiple suggest a pull‑back in buying interest.
Market effects
Highlights valuation contrasts within health‑care, semiconductors, and biotech screening sectors.
U.S. market focus; no specific regional effect beyond individual stocks.
Limited to investors tracking these three companies.
Counterpoint
Some investors may view CVS's 340B pressure and ON's cash‑heavy Synaptics deal as lingering risks.
Key entities
- Analyst/HostJim Cramer
Host of Mad Money, providing stock commentary.
